Particle Therapy Market : Analysis of Worldwide Industry Trends and Opportunities
According to the new market research report “ Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) – Forecast to 2023“, published by MarketsandMarkets™, global particle therapy market is projected to reach...
Particle Therapy Market Worth USD 1,349 Million : Technological Advancements In The Field Of Proton Therapy
Expected Revenue Growth :
The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.
What This Report Will Provide?
The study involved four major activities to estimate the current market size for particle therapy. Exhaustive secondary research was done to collect information on the market and its...
Particle Therapy Market : Increasing Number of Particle Therapy Centers Worldwide
The particle therapy market comprises several stakeholders such as particle therapy product manufacturers, suppliers and distributors, healthcare service providers, and research institutes. The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer.
Growth in the particle...
Particle Therapy Market | APAC Market is Expected to Grow at the Fastest Rate
Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.
The global particle therapy market is projected to reach USD 1,349 million by...
Growing Adoption of Particle Therapy in Clinical Trials : Increasing Market Opportunities
The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.
The advantages offered by particle therapy over photon therapy, the growing global prevalence of cancer, growing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide are the major factors driving the growth of...